Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

Mammoth’s proprietary ultracompact CRISPR-based gene editing platform and Regeneron’s proprietary delivery technologies set to advance in vivo programs in multiple tissue and cell types Mammoth...

Related Keywords

Lucas Harrington ,Zella Campbell ,Trevor Martin ,John Kang ,Jennifer Doudna ,Janice Chen ,Vesna Tosic ,Elaine Sun ,Nasdaq ,Linkedin ,Facebook ,Regeneron Genetics Center ,Doudna Lab At University Of California Berkeley ,Regeneron Pharmaceuticals Inc ,Exchange Commission ,Biosciences Inc ,Instagram ,Mammoth Biosciences ,Christos Kyratsous ,Senior Vice President ,Regeneron Genetic Medicines ,Doudna Lab ,Chief Executive Officer ,Scientific Advisory Board ,Regeneron Genetics ,Regeneron Pharmaceuticals ,Mammoth Bioscience ,Product Candidates ,Markets ,